Pacira Biosciences, Inc. (PCRX)
24.96
+0.10
(+0.40%)
USD |
NASDAQ |
Aug 25, 11:28
Pacira Biosciences Debt to Equity Ratio : 0.6133 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6133 |
| March 31, 2026 | 0.6288 |
| December 31, 2025 | 0.6034 |
| September 30, 2025 | 0.5848 |
| June 30, 2025 | 0.8332 |
| March 31, 2025 | 0.797 |
| December 31, 2024 | 0.8208 |
| September 30, 2024 | 0.8597 |
| June 30, 2024 | 0.7376 |
| March 31, 2024 | 0.6521 |
| December 31, 2023 | 0.6735 |
| September 30, 2023 | 0.7099 |
| June 30, 2023 | 0.7682 |
| March 31, 2023 | 0.814 |
| December 31, 2022 | 0.985 |
| September 30, 2022 | 1.067 |
| June 30, 2022 | 1.099 |
| March 31, 2022 | 1.411 |
| December 31, 2021 | 1.546 |
| September 30, 2021 | 0.7717 |
| June 30, 2021 | 0.7993 |
| March 31, 2021 | 0.8361 |
| December 31, 2020 | 0.8732 |
| September 30, 2020 | 0.9174 |
| June 30, 2020 | 1.019 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9471 |
| December 31, 2019 | 0.9915 |
| September 30, 2019 | 0.9995 |
| June 30, 2019 | 1.005 |
| March 31, 2019 | 1.005 |
| December 31, 2018 | 0.9057 |
| September 30, 2018 | 0.9534 |
| June 30, 2018 | 0.9762 |
| March 31, 2018 | 1.005 |
| December 31, 2017 | 0.9893 |
| September 30, 2017 | 1.031 |
| June 30, 2017 | 1.033 |
| March 31, 2017 | 0.9857 |
| December 31, 2016 | 0.4966 |
| September 30, 2016 | 0.5023 |
| June 30, 2016 | 0.4659 |
| March 31, 2016 | 0.4652 |
| December 31, 2015 | 0.485 |
| September 30, 2015 | 0.5019 |
| June 30, 2015 | 0.532 |
| March 31, 2015 | 0.5659 |
| December 31, 2014 | 0.604 |
| September 30, 2014 | 0.6621 |
| June 30, 2014 | 0.6887 |
| March 31, 2014 | 2.83 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Zimmer Biomet Holdings, Inc. | 0.5924 |
| Liquidia Corp. | 0.9374 |
| Johnson & Johnson | 0.5771 |
| Merck & Co., Inc. | 1.286 |
| ANI Pharmaceuticals, Inc. | 1.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.244B |
| Total Liabilities (Quarterly) | 572.00M |
| Shareholders Equity (Quarterly) | 671.98M |
| Current Ratio | 5.042 |
| Net Debt Paydown Yield | 4.44% |